You are viewing: UK Endoscopic Submucosal Dissection/ESD Market analysis

The UK Endoscopic Submucosal Dissection/ESD Market was valued at $7.4 Million in 2025 and projected to reach to $11.8 Million by 2030, representing a compound annual growth rate of 9.8%. The UK ESD market is positioned for sustained growth through 2030, underpinned by the NHS's commitment to advancing endoscopic capabilities and reducing patient recovery times.

UK Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • The UK market is benefiting from increasing adoption of minimally invasive gastrointestinal procedures and rising prevalence of early-stage gastric and colorectal lesions.
  • The UK healthcare system's emphasis on advanced endoscopic techniques and improved patient outcomes is driving demand for ESD procedures across NHS trusts and private healthcare facilities. Key growth factors in the UK include enhanced training programs for endoscopists, growing awareness among gastroenterologists, and investment in endoscopic equipment infrastructure.
  • The UK market is also supported by favorable reimbursement policies and clinical guidelines promoting ESD as a preferred treatment modality for early neoplastic lesions.
  • Between 2025 and 2030, the UK is expected to see accelerated adoption as procedural volumes increase and technology becomes more accessible across regional healthcare networks..

Key Market Statistics

  • CAGR (2025-2030) 9.8% CAGR
  • Market Size, 2025 ~USD 7.4 Million
  • Forecast, 2030 ~USD 11.8 Million
  • Country UK

UK Endoscopic Submucosal Dissection/ESD Market Overview

Market Size & Growth :

The UK ESD market is valued at £7.4 million in 2025 and is projected to reach £11.8 million by 2030, driven by a robust CAGR of 9.8%, significantly outpacing the global average of 8.4%.

NHS Integration & Adoption :

Increasing adoption of minimally invasive gastrointestinal procedures within NHS trusts is accelerating ESD uptake across UK hospitals, particularly in specialist endoscopy centres and tertiary care facilities.

Clinical Prevalence Drivers :

Rising prevalence of early-stage gastric and colorectal lesions in the UK population, combined with improved screening programmes, is creating sustained demand for advanced endoscopic therapeutic interventions.

Healthcare System Support :

The UK healthcare system's emphasis on cost-effective, minimally invasive treatments aligns with ESD's clinical benefits, supporting reimbursement pathways and procedural standardisation across regional NHS networks.

UK Endoscopic Submucosal Dissection/ESD Market Dynamics

  • Increasing investment in specialist endoscopy training programmes and equipment modernisation across UK hospitals will expand procedural capacity.
  • Additionally, growing awareness among gastroenterologists and colorectal specialists regarding ESD's superiority over traditional resection methods is driving clinical adoption.
  • Regulatory support and NICE guidance developments are expected to further facilitate market expansion, particularly in early-stage lesion management across both gastric and colorectal indications..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The UK ESD market is valued at £7.4 million in 2025 and will reach £11.8 million by 2030, growing at 9.8% CAGR.
    • The UK is experiencing increased adoption of minimally invasive endoscopic procedures driven by NHS investment and clinical guideline updates.
    • Enhanced endoscopist training and awareness programs across UK healthcare institutions are accelerating ESD procedure uptake.
    • The UK market benefits from favorable reimbursement policies and strong demand for tissue-preserving treatment alternatives in the UK healthcare system.

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    UK Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGICAL CENTERS2.192.362.612.843.133.433.764.129.5
    HOSPITALS8.118.779.7610.6711.7712.9814.2715.7210
    OTHER END USERS0.310.330.360.390.420.450.490.538.2
    SPECIALTY CLINICS2.732.943.253.523.864.224.615.049.2
    TOTAL13.3414.3915.9817.4219.1721.0923.1325.419.7

    Target Audience

    • UK Medical Device Manufacturers : Require detailed UK market data to assess commercial opportunities, benchmark competitive positioning, and develop targeted sales strategies for ESD equipment and accessories within British hospitals.
    • NHS Hospital Procurement Teams : Need market intelligence to justify capital expenditure on ESD technology, evaluate supplier options, and align purchasing decisions with clinical guidelines and budget constraints across NHS trusts.
    • UK Gastroenterology Specialists : Seek market insights to understand adoption trends, training opportunities, and procedural volume forecasts that inform career planning and departmental investment in ESD capabilities.
    • Private Healthcare Operators : Require UK-specific market data to identify growth opportunities in private endoscopy centres, assess patient demand for ESD procedures, and develop competitive service offerings.
    • Healthcare Investors & Consultants : Need comprehensive UK market analysis to evaluate investment opportunities in endoscopy technology, assess market dynamics, and provide strategic recommendations to healthcare stakeholders.

    Key Companies in the UK Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Obtain precise market valuation and forecasting data tailored exclusively to the UK market, enabling accurate budget allocation and investment decisions for UK-based healthcare providers and medical device manufacturers.
    • NHS Reimbursement Insights : Understand UK-specific reimbursement pathways, NICE guidance trends, and NHS procurement patterns that directly influence ESD adoption rates and commercial viability within the British healthcare system.
    • Competitive Landscape Analysis : Identify key UK market players, regional hospital networks, and specialist endoscopy centres driving ESD adoption, enabling targeted market entry and partnership strategies specific to the UK healthcare ecosystem.
    • Clinical Adoption Drivers : Analyse UK-specific factors including screening programme expansion, gastroenterologist training initiatives, and patient demographics influencing ESD procedure volumes and market growth trajectories.
    • Strategic Growth Planning : Leverage UK market intelligence to develop region-specific commercial strategies, identify high-growth hospital networks, and optimise product positioning for the British endoscopy market through 2030.

    Frequently asked questions

    What is the current size of the UK ESD market?

    The UK Endoscopic Submucosal Dissection market is estimated at £7.4 million in 2025.

    What is the projected size of the UK ESD market by 2030?

    The UK ESD market is forecast to reach £11.8 million by 2030, representing 59% growth from 2025.

    What is the growth rate of the UK ESD market?

    The UK ESD market is expected to grow at a compound annual growth rate (CAGR) of 9.8% between 2025 and 2030.

    What factors are driving growth in the UK ESD market?

    Key drivers include increased NHS investment in endoscopic infrastructure, enhanced endoscopist training programs, favorable reimbursement policies, and rising clinical adoption of minimally invasive procedures across UK healthcare facilities.

    Which UK healthcare providers are adopting ESD procedures?

    Both NHS trusts and private healthcare facilities across the UK are increasingly adopting ESD procedures as part of their gastrointestinal treatment portfolios.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status